Fulcrum India Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.90 M
- Revenue Growth 84.04%
- Profit Growth 56.84%
- Ebitda 190.01%
- Net Worth 143.28%
- Total Assets 73.13%
About Fulcrum India Lifesciences
Fulcrum India Lifesciences Private Limited (FILPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2021 (Three years and 11 months 2 days old ). Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹6.90 M.
Vinod Sharma, Awadhesh Tripathi, Vijay Srivastava, and Five other members serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51909UP2021PTC143376
-
Company No.
143376
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Mar 2021
-
Date of AGM
23 Aug 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Fulcrum India Lifesciences?
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lucky Tripathi
|
Director | 04-May-2022 | Current |
|
Vinod Sharma
|
Director | 12-Mar-2021 | Current |
|
Awadhesh Tripathi
|
Director | 12-Mar-2021 | Current |
|
Vijay Srivastava
|
Director | 12-Mar-2021 | Current |
|
Subhash Mamgain
|
Director | 12-Mar-2021 | Current |
|
Jaya Sharma
|
Director | 04-May-2022 | Current |
Financial Performance of Fulcrum India Lifesciences.
Fulcrum India Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 84.04% increase. The company also saw a substantial improvement in profitability, with a 56.84% increase in profit. The company's net worth Soared by an impressive increase of 143.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Fulcrum India Lifesciences?
Unlock access to Fulcrum India Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹6.90 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.69 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Oct 2023 | Hdfc Bank Limited | ₹4.00 M | Open |
| 26 Apr 2022 | Hdfc Bank Limited | ₹1.61 M | Open |
| 21 Mar 2022 | Hdfc Bank Limited | ₹1.29 M | Open |
How Many Employees Work at Fulcrum India Lifesciences?
Fulcrum India Lifesciences has a workforce of 34 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Fulcrum India Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Fulcrum India Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.